The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma.
The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma.
复制标题
DOI：
10.18632/oncotarget.4965
复制
发表时间：
2015-10-06
期刊：
影响因子：
--
通讯作者：
Storz P
中科院分区：
文献类型：
--
作者：
Döppler H;Bastea L;Borges S;Geiger X;Storz P
Vasodilator-stimulated phosphoprotein (VASP) signaling is critical for dynamic actin reorganization processes that define the motile phenotype of cells. Here we show that VASP is generally highly expressed in normal breast tissue and breast cancer. We also show that the phosphorylation status of VASP at S322 can be predictive for breast cancer progression to an aggressive phenotype. Our data indicate that phosphorylation at S322 is gradually decreased from normal breast to DCIS, luminal/ER+, HER2+ and basal-like/TN phenotypes. Similarly, the expression levels of PKD2, the kinase that phosphorylates VASP at this site, are decreased in invasive ductal carcinoma samples of all three groups. Overall, the phosphorylation status of this residue may serve as an indicator of aggressiveness of breast tumors.
